Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform

Anti-Vascular Endothelial Growth Factor Therapy as an Alternative or Adjunct to Pan-Retinal Photocoagulation in Treating Proliferative Diabetic Retinopathy: Meta-Analysis of Randomized Trials

(2020) Shuang Gao et al.   Frontiers in Pharmacology

Characterization of Subpopulations of Chicken Mononuclear Phagocytes That Express TIM4 and CSF1R

(2019) Tuanjun Hu et al.   JOURNAL OF IMMUNOLOGY

Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications

(2019) F. Semeraro et al.   DIABETES & METABOLISM

Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications

(2019) Imtiaz M. Nawaz et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Vascular Endothelial Growth Factor in the Vitreous of Proliferative Diabetic Retinopathy Patients: Chasing a Hiding Prey?

(2019) Sara Rezzola et al.   DIABETES CARE

Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy

(2018) Jing Xu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Endothelial Cell Metabolism

(2018) Guy Eelen et al.   PHYSIOLOGICAL REVIEWS

Sweet Stress: Coping With Vascular Dysfunction in Diabetic Retinopathy

(2018) Ana R. Santiago et al.   Frontiers in Physiology

Hyaluronic Acid/Bone Substitute Complex Implanted on Chick Embryo Chorioallantoic Membrane Induces Osteoblastic Differentiation and Angiogenesis, but not Inflammation

(2018) Laura Cirligeriu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Tumor angiogenesis revisited: Regulators and clinical implications

(2017) Roberto Ronca et al.   MEDICINAL RESEARCH REVIEWS

Zebrafish ( Danio rerio ) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases

(2016) Sara Rezzola et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The chick embryo chorioallantoic membrane (CAM). A multifaceted experimental model

(2016) Domenico Ribatti   MECHANISMS OF DEVELOPMENT

The progress in understanding and treatment of diabetic retinopathy

(2016) Alan W. Stitt et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Therapeutic Potential of Anti-Angiogenic Multitarget N,O -Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy

(2015) Sara Rezzola et al.   DIABETES

Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth

(2015) Nella Prevete et al.   PHARMACOLOGICAL RESEARCH

Diabetic Retinopathy: Vascular and Inflammatory Disease

(2015) F. Semeraro et al.   Journal of Diabetes Research

Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future

(2014) Tsong Qiang Kwong et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The chick embryo chorioallantoic membrane as a model for tumor biology

(2014) Domenico Ribatti   EXPERIMENTAL CELL RESEARCH

Formation of Microvascular Networks: Role of Stromal Interactions Directing Angiogenic Growth

(2014) James B. Hoying et al.   MICROCIRCULATION

UPARANT: A Urokinase Receptor-Derived Peptide Inhibitor of VEGF-Driven Angiogenesis with Enhanced Stability and In Vitro and In Vivo Potency

(2014) M. V. Carriero et al.   MOLECULAR CANCER THERAPEUTICS

Angiogenic Potential of Vitreous from Proliferative Diabetic Retinopathy and Eales' Disease Patients

(2014) Ponnalagu Murugeswari et al.   PLoS One

Identification of Chemokines and Growth Factors in Proliferative Diabetic Retinopathy Vitreous

(2014) Ying Dai et al.   Biomed Research International

Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy

(2013) Sirpa Loukovaara et al.   ACTA OPHTHALMOLOGICA

In vitro and ex vivo retina angiogenesis assays

(2013) Sara Rezzola et al.   ANGIOGENESIS

Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases

(2013) Ramya Vadlapatla et al.   CURRENT DRUG TARGETS

The avian heterophil

(2013) Kenneth J. Genovese et al.   DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY

Microvascular complications and diabetic retinopathy: recent advances and future implications

(2013) Megha Barot et al.   Future Medicinal Chemistry

Vitreous Mediators in Retinal Hypoxic Diseases

(2013) Roberto dell'Omo et al.   MEDIATORS OF INFLAMMATION

Novel drugs and their targets in the potential treatment of diabetic retinopathy

(2013) Mohammad Shamsul Ola   MEDICAL SCIENCE MONITOR

Pathophysiology and treatment of diabetic retinopathy

(2012) Francesco Bandello et al.   ACTA DIABETOLOGICA

Novel Targets Against Retinal Angiogenesis in Diabetic Retinopathy

(2012) Shuang Wang et al.   Current Diabetes Reports

“Sprouting angiogenesis”, a reappraisal

(2012) Domenico Ribatti et al.   DEVELOPMENTAL BIOLOGY

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

(2012) J. W. Y. Yau et al.   DIABETES CARE

Diabetic Retinopathy

(2012) David A. Antonetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vascular Endothelial Growth Factor A in Intraocular Vascular Disease

(2012) Joan W. Miller et al.   OPHTHALMOLOGY

Animal welfare and the 3Rs in European biomedical research

(2011) Dominic J. Wells   Annals of the New York Academy of Sciences

Basic and Therapeutic Aspects of Angiogenesis

(2011) Michael Potente et al.   CELL

Microvascular Modifications in Diabetic Retinopathy

(2011) Jennifer T. Durham et al.   Current Diabetes Reports

Anti-inflammatory therapy for diabetic retinopathy

(2011) Wenbo Zhang et al.   Immunotherapy

Inflammation in diabetic retinopathy

(2011) Johnny Tang et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications

(2010) Pedro Geraldes et al.   CIRCULATION RESEARCH

An Intact Canonical NF- B Pathway Is Required for Inflammatory Gene Expression in Response to Hypoxia

(2010) S. F. Fitzpatrick et al.   JOURNAL OF IMMUNOLOGY

The modified HET-CAM as a model for the assessment of the inflammatory response to tissue tolerable plasma

(2010) Claudia Bender et al.   TOXICOLOGY IN VITRO

The Role of NF-κB in Hypoxia-Induced Gene Expression

(2009) Cormac T. Taylor et al.   Annals of the New York Academy of Sciences

(Pro)renin Receptor-Mediated Signal Transduction and Tissue Renin-Angiotensin System Contribute to Diabetes-Induced Retinal Inflammation

(2009) S. Satofuka et al.   DIABETES

Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications

(2009) Ronald B. Goldberg   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

(2009) R. D. Ye et al.   PHARMACOLOGICAL REVIEWS

Sequential delivery of dexamethasone and VEGF to control local tissue response for carbon nanotube fluorescence based micro-capillary implantable sensors

(2008) Jaeyun Sung et al.   BIOMATERIALS

A pro-inflammatory signature mediates FGF2-induced angiogenesis

(2008) Germán Andrés et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α

(2008) Jordi Rius et al.   NATURE

Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy

(2008) Hamid Ahmadieh et al.   OPHTHALMOLOGY

A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema

(2008)   OPHTHALMOLOGY